IREN LTD (IREN) Fundamental Analysis & Valuation

NASDAQ:IREN • AU0000185993

Current stock price

44.94 USD
+3.36 (+8.08%)
At close:
44.94 USD
0 (0%)
After Hours:

This IREN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. IREN Profitability Analysis

1.1 Basic Checks

  • In the past year IREN was profitable.
  • In the past year IREN had a positive cash flow from operations.
  • In the past 5 years IREN reported 4 times negative net income.
  • In the past 5 years IREN always reported a positive cash flow from operatings.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • IREN has a Return On Assets of 12.26%. This is amongst the best in the industry. IREN outperforms 89.53% of its industry peers.
  • Looking at the Return On Equity, with a value of 18.19%, IREN belongs to the top of the industry, outperforming 85.92% of the companies in the same industry.
Industry RankSector Rank
ROA 12.26%
ROE 18.19%
ROIC N/A
ROA(3y)-17.1%
ROA(5y)-33.96%
ROE(3y)-18.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • Looking at the Profit Margin, with a value of 76.17%, IREN belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
  • IREN's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 49.79%, IREN is not doing good in the industry: 69.31% of the companies in the same industry are doing better.
Industry RankSector Rank
OM N/A
PM (TTM) 76.17%
GM 49.79%
OM growth 3Y14.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IREN Health Analysis

2.1 Basic Checks

  • IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IREN has been increased compared to 1 year ago.
  • The number of shares outstanding for IREN has been increased compared to 5 years ago.
  • Compared to 1 year ago, IREN has a worse debt to assets ratio.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 6.35 indicates that IREN is not in any danger for bankruptcy at the moment.
  • IREN has a better Altman-Z score (6.35) than 82.31% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that IREN is not too dependend on debt financing.
  • IREN has a worse Debt to Equity ratio (0.34) than 61.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 6.35
ROIC/WACCN/A
WACC11.21%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 5.52 indicates that IREN has no problem at all paying its short term obligations.
  • IREN has a better Current ratio (5.52) than 87.00% of its industry peers.
  • A Quick Ratio of 5.52 indicates that IREN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 5.52, IREN belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.52
Quick Ratio 5.52
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. IREN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 618.29% over the past year.
  • The Revenue has grown by 163.17% in the past year. This is a very strong growth!
  • The Revenue has been growing by 196.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)618.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.04%
Revenue 1Y (TTM)163.17%
Revenue growth 3Y103.98%
Revenue growth 5Y196.84%
Sales Q2Q%62.75%

3.2 Future

  • Based on estimates for the next years, IREN will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.67% on average per year.
  • Based on estimates for the next years, IREN will show a very strong growth in Revenue. The Revenue will grow by 53.20% on average per year.
EPS Next Y-21.87%
EPS Next 2Y-68.96%
EPS Next 3Y-27.67%
EPS Next 5YN/A
Revenue Next Year105.74%
Revenue Next 2Y134.96%
Revenue Next 3Y88.45%
Revenue Next 5Y53.2%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. IREN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.44 indicates a quite expensive valuation of IREN.
  • IREN's Price/Earnings ratio is a bit cheaper when compared to the industry. IREN is cheaper than 62.82% of the companies in the same industry.
  • IREN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.96, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for IREN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 26.44
Fwd PE N/A
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • IREN's earnings are expected to decrease with -27.67% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.96%
EPS Next 3Y-27.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IREN Dividend Analysis

5.1 Amount

  • IREN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IREN Fundamentals: All Metrics, Ratios and Statistics

IREN LTD

NASDAQ:IREN (3/16/2026, 8:00:03 PM)

After market: 44.94 0 (0%)

44.94

+3.36 (+8.08%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)05-12
Inst Owners49.53%
Inst Owner ChangeN/A
Ins Owners3.56%
Ins Owner Change0%
Market Cap14.93B
Revenue(TTM)752.03M
Net Income(TTM)523.26M
Analysts80
Price Target76.28 (69.74%)
Short Float %13.89%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)440.84%
Min EPS beat(2)319.92%
Max EPS beat(2)561.77%
EPS beat(4)3
Avg EPS beat(4)305.97%
Min EPS beat(4)-22.73%
Max EPS beat(4)561.77%
EPS beat(8)4
Avg EPS beat(8)-255.39%
EPS beat(12)6
Avg EPS beat(12)-201.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-0.52%
Revenue beat(4)1
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-8.9%
Max Revenue beat(4)1.42%
Revenue beat(8)3
Avg Revenue beat(8)-2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.71%
PT rev (3m)-6.81%
EPS NQ rev (1m)-12.89%
EPS NQ rev (3m)-5525%
EPS NY rev (1m)-54.34%
EPS NY rev (3m)-43.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)-10.44%
Revenue NY rev (3m)-10.96%
Valuation
Industry RankSector Rank
PE 26.44
Fwd PE N/A
P/S 21.74
P/FCF N/A
P/OCF 38.09
P/B 5.19
P/tB 5.19
EV/EBITDA N/A
EPS(TTM)1.7
EY3.78%
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)1.18
OCFY2.63%
SpS2.07
BVpS8.66
TBVpS8.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.2
Profitability
Industry RankSector Rank
ROA 12.26%
ROE 18.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 76.17%
GM 49.79%
FCFM N/A
ROA(3y)-17.1%
ROA(5y)-33.96%
ROE(3y)-18.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 108.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.52
Quick Ratio 5.52
Altman-Z 6.35
F-Score5
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)114.65%
Cap/Sales(5y)115.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)618.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.04%
EPS Next Y-21.87%
EPS Next 2Y-68.96%
EPS Next 3Y-27.67%
EPS Next 5YN/A
Revenue 1Y (TTM)163.17%
Revenue growth 3Y103.98%
Revenue growth 5Y196.84%
Sales Q2Q%62.75%
Revenue Next Year105.74%
Revenue Next 2Y134.96%
Revenue Next 3Y88.45%
Revenue Next 5Y53.2%
EBIT growth 1Y82.52%
EBIT growth 3Y132.63%
EBIT growth 5YN/A
EBIT Next Year746.51%
EBIT Next 3Y256.75%
EBIT Next 5Y122.45%
FCF growth 1Y-265.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y370.88%
OCF growth 3Y125.1%
OCF growth 5YN/A

IREN LTD / IREN Fundamental Analysis FAQ

What is the fundamental rating for IREN stock?

ChartMill assigns a fundamental rating of 4 / 10 to IREN.


What is the valuation status of IREN LTD (IREN) stock?

ChartMill assigns a valuation rating of 1 / 10 to IREN LTD (IREN). This can be considered as Overvalued.


How profitable is IREN LTD (IREN) stock?

IREN LTD (IREN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for IREN stock?

The Earnings per Share (EPS) of IREN LTD (IREN) is expected to decline by -21.87% in the next year.